Bayer/GSK Levitra Sales Top $100 Mil.; New ED Patient Share Growing
More than 40% of new prescriptions for Bayer/ GlaxoSmithKline's Levitra are for previously undiagnosed erectile dysfunction patients, Bayer CFO Klaus Kuhn told investors Nov. 11
You may also be interested in...
Bayer will focus on seeking licensing deals for its pharmaceutical business after abandoning a search for a more extensive partnership, CEO Werner Wenning told analysts Nov. 11
Pfizer sees more savings from Pharmacia: Pfizer is now projecting "at least" $1 bil. in synergies from the Pharmacia acquisition in 2003, indicating that it expects to exceed its original target of $1 bil. in first-year savings...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011